Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Feb 26, 2020, after the close
10-K filed Feb 26, 2020, 57 days after period end · 0001564590-20-006830
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|
| Revenue | $24.21M | — |
| Net Income | -$20.61M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Feb 26, 2020 · 57 d after period end
5.2% from the close of Feb 26, 2020 to the close of Feb 28, 2020, the first after the release.